Actively Recruiting

Phase Not Applicable
Age: 75Years +
All Genders
ID07001423

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

Led by Helsinki University Central Hospital · Updated on 2025-10-07

400

Participants Needed

12

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to compare the safety and effectiveness of laparoscopic cholecystectomy versus a wait-and-see approach in elderly patients who have had common bile duct stones successfully removed using endoscopy. The study focuses on patients 75 years and older, including those with additional health issues, to determine if avoiding surgery is as safe as performing cholecystectomy. The main measurement is a combined outcome of death, serious complications, or recurring biliary problems within one year after randomization. Participants are randomly assigned to one of two groups: one will have laparoscopic cholecystectomy within two weeks following stone removal, and the other will be managed without surgery but can have cholecystectomy later if needed. The study includes an interim safety check after the first 100 participants, with a plan to stop early if significant differences arise. Both groups are monitored over time to assess health outcomes and complications. During the study, participants will be followed for at least one year to track outcomes such as survival, complications, biliary events, quality of life, pain, and healthcare costs. Assessments occur at various intervals, including 30, 180, and 365 days after randomization. Researchers will evaluate these factors carefully to understand the benefits and risks of each approach, ensuring participant safety throughout the trial.

CONDITIONS

Brief Title

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

Who Can Participate

Age: 75Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
  • Age 80 years or older, or age 75-79 years with a Charlson Comorbidity index of 2 or higher
  • Gallbladder still in place
Not Eligible

You will not qualify if you...

  • Acute cholecystitis
  • Biliary pancreatitis
  • Severe or moderately severe post-ERCP pancreatitis
  • Chronic pancreatitis
  • Bile duct pathology
  • Widespread malignancy
  • Unable to give consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 2 weeks after randomization

Participants receive laparoscopic cholecystectomy within 2 weeks after endoscopic removal of common bile duct stones or are managed with a wait-and-see approach.

1 baseline visit and multiple follow-up visits up to 1 year

Follow-up

Duration - Up to 2 years

Participants are monitored for outcomes including complications, recurrent biliary events, and survival for up to 2 years after randomization.

Visits at 30 days, 180 days, 365 days, and additional assessments up to 2 years

Trial Site Locations

Total: 12 locations

1

Helsinki University Hospital, Jorvi

Espoo, Finland

Actively Recruiting

2

Kanta-Häme Central Hospital

Hämeenlinna, Finland

Not Yet Recruiting

3

Helsinki University Hospital, Meilahti

Helsinki, Finland

Actively Recruiting

4

Pohjois-Karjala Central Hospital

Joensuu, Finland

Not Yet Recruiting

5

Keski-Suomi Central Hospital

Jyväskylä, Finland

Not Yet Recruiting

6

Kymenlaakso Central Hospital

Kotka, Finland

Not Yet Recruiting

7

Kuopio University Hospital

Kuopio, Finland

Not Yet Recruiting

8

Päijät-Häme Central Hospital

Lahti, Finland

Not Yet Recruiting

9

Oulu University Hospital

Oulu, Finland

Not Yet Recruiting

10

Tampere University Hospital

Tampere, Finland

Not Yet Recruiting

11

Turku University Hospital

Turku, Finland

Not Yet Recruiting

12

Vaasa Central Hospital

Vaasa, Finland

Not Yet Recruiting

Loading map...

Research Team

P

Panu Mentula, MD, PhD

P

Päivi Siironen, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Application of Machine Learning Models to Reduce Need for Di...

Choledocholithiasis

Actively Recruiting

1 location

Association Between Intraoperative Bispectral Index Variabil...

Bispectral Index Variability During General Anesthesia and Postoperative Recovery

Actively Recruiting

1 location

Clinical Study of Single Incision Laparoscopic Cholecystecto...

Cholecystectomy, Laparoscopic

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Wait-and-see strategy is justified after ERCP and endoscopic sphincterotomy in elderly patients with common biliary duct stones.

Antti Kivivuori, Laura Mattila, Antti Siiki...

https://pubmed.ncbi.nlm.nih.gov/36524923

Routine laparoscopic cholecystectomy after endoscopic sphincterotomy for choledocholithiasis in octogenarians: is it worth the risk?

R Costi, D DiMauro, A Mazzeo...

https://pubmed.ncbi.nlm.nih.gov/17111279

Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial.

Djemila Boerma, Erik A J Rauws, Yolande C A Keulemans...

https://pubmed.ncbi.nlm.nih.gov/12241833

Patients over 65 years with Acute Complicated Calculous Biliary Disease are Treated Differently-Results and Insights from the ESTES Snapshot Audit.

Gary A Bass, Amy E Gillis, Yang Cao...

https://pubmed.ncbi.nlm.nih.gov/33813631